GSK says investigating claims of bribery in Jordan, Lebanon

LONDON, April 16 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Iraq and Poland.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.